Several neuropsychiatric disorders such as attention deficit-hyperactivity disorder (ADHD), autism spectrum disorder (ASD), as well as neurological diseases such as spinocerebellar ataxia type 3 (SCA3 ...

The cerebellum has been repeatedly implicated in gene expression ... The mechanisms that contribute to walking abnormalities remain unclear as patterns do not cleanly fit with models of ataxia, basal ...

2 Gluten ataxia is the commonest single cause of cerebellar ataxia among patients with supposed idiopathic sporadic ataxia. Overall, these studies suggest variable responsiveness to treatment. In some ...

Clinical features include impaired vigilance, dysphagia, dysarthria and limb weakness (9). The neurodegenerative disorder MSA is an α-synucle-inopathy that presents with a combination of parkinsonism, ...

In a study published in the journal Current Biology, Johns Hopkins researchers discovered that individual neurons in the ...

Sensory processing disorder—also known as SPD or sensory integration disorder—is a term describing a collection of challenges that occur when the senses fail to respond properly to the outside ...

The authors provide convincing evidence that the cerebellum represents sensory, motor, and behavioral outcome signals that are sent to the attentional system. This paper is of great general interest ...

Cerebellar patients exhibit various motor impairments, but the sequence of primary and compensatory processes leading to these deficits remains unclear. To investigate this, we reversibly blocked ...

For example, subacute cerebellar ataxia in the setting of ovarian cancer is sufficiently characteristic to ... 2 Among 1465 patients with all different cancers, only 15 had cerebellar degeneration and ...

Dystonia typically presents in cases of cerebellar degeneration where other parts of the brain are also affected. In addition, jerky movements in the limbs can be a symptom of ataxia, which is a ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.